Video Capsule Endoscopy for Identifying Crohn’s Disease Crohn’s disease is a form of inflammatory bowel disease (IBD) that could occur anywhere from the mouth to the rectum. However, it usually affects the intestines (Longstreth, 2010). Like many illnesses, there is no cure for Crohn’s as the exact cause of it is unknown. There are a number of tests and procedures available that aide in making the diagnosis of Crohn’s disease. Stool cultures and blood work can suggest IBD but may not directly
Wireless Capsule Endoscopy Etinosa Ekomwenrenren Student ID: 200990550 The University of Leeds School of Electronic and Electrical Engineering April 2017 Table of Contents Abstract iii List of Abbreviations iv List of Figures v List of Tables vi Chapter 1 Introduction 1 Chapter 2 Wireless capsule endoscopy: past and present 2 2.1 History of wireless capsule endoscopy 2 2.2 Current wireless capsule endoscope systems 4 2.3 Clinical utility of wireless capsule endoscopy 7 2.3.1 Small bowel
Abstract The visualization of the small bowel has posed a challenge to gastroenterologists due to the difficulty of physically reaching more distal regions of the small bowel anatomically. As the small bowel can often be a source of pathology, endoscopy of the small bowel can be a useful diagnostic and therapeutic technique. Over the last few years’ enteroscopies has been introduced and being used widely. Various types of enteroscopies are being used; among them the most commonly used are double
It can be inferred from the preceding research that anorexia nervosa, bulimia, and obesity are all multifactorial disorders. Each requires a slightly different approach, yet there are effective alternate solutions for all three. Anorexia is most effectively treated by nutrient therapy. Physical health is the top priority in anorexic patients because the disorder takes a large toll on the body. Critical conditions pushes care to a near-emergency level because the body can easily shutdown due to extreme
Non-Hodgkin’s lymphoma is one of the most common types of cancers in the United States that affect mostly older adults. The American Cancer Society estimates that 72,580 people in the Unites States will be diagnosed with the disease just in the year 2016 alone. Of that number, there are about 20,150 people expected to die from the disease. There is also a 2% chance of people in the United States developing the disease (American cancer society, n.d.). There have been many researches done about the
Crohn’s Disease was named after an American gastroenterologist, Dr. Burrill Bernard Crohn, in 1932. He and his colleagues discovered an abnormal pathogen, Mycobacterium paratuberculosis while studying a related disease, ulcerative colitis, which belongs to a larger group if illnesses called Inflammatory Bowel Disease (IBD). The discovery was made while studying the effects of ulcerative colitis in cattle and noticing the similar characteristics in humans. The infections had an abnormal response
triple therapy from 7 to 10 days and found no additional benefit for patients with peptic ulcers. There was, however, a significant benefit for nonulcer dyspepsia patients (an increase from 66% to 77% in the intention-to-treat analysis and from 73% to 91% in the per-protocol analysis). The authors concluded that the treatment period should be extended from 7 to 10 days for patients with nonulcer dyspepsia. As most eradication therapy, however, is given to patients with uninvestigated dyspepsia, it is not
FOR A GASTROENTEROLOGY ENDOSCOPY COMMUNITY OF PRACTICE A Clinical Capstone Proposal Presented to the Faculty of the School of Health Sciences La Salle University In Fulfillment Of the Requirements for the Degree Doctor of Nursing Practice By Jordan Hopchik Doctor of Nursing Practice Program COPYRIGHT BY JORDAN HOPCHIK 2014 Title of Clinical Capstone Proposal: A NEEDS ASSESSMENT SURVEY FOR A GASTROENTEROLOGY ENDOSCOPY COMMUNITY OF
all › 41 Reads Download Add supplementary resources Recommend Portal vein thrombosis in patients with liver cirrhosis: insights to risk factors, clinical presentation and outcome Article in International Journal of Advanced Research 3(12):1539-1548 · December 2015 1st Afifi F Afifi 2nd Osama Basha 6.99 · Zagazig University + 1 3rd Fady Maher Zagazig University Last Raghda Abd Ellatif Hafez 16.2 · Faculty of medicine/Zagazig University.www.zu.edu.eg Show more authors 3 elements are still missing
Pharmacotherapy Workup © NOTES CARE PLAN PATIENT INITIALS: JF DATE: OCT 22TH, 2014 GERD (NESA) Patient Background History JF is a 79-year-old retired female who was brought to our attention with chief complains of ongoing cramping in her legs since 3-4 months ago. She is about 160 cm tall and weighs ~68 Kg (BMI 26.6). The possibilities of a statin-induced myalgia will be discussed in her dyslipidemia PCP. JF’s current